Table 1.
Characteristics of Participants (N = 301)
M ± SD or N(%) | |
---|---|
Demographic, Medical, and Psychosocial Factors (Possible Range) | |
Age | 68.7 ± 9.7 |
Female | 150 (40.3) |
Non-whitea | 104 (28.0) |
Education Level | |
8th Grade or Less | 10 (2.7) |
9–11th Grade | 37 (9.9) |
High School | 100 (26.9) |
Technical or Trade School | 38 (10.2) |
Some College | 102 (27.4) |
Bachelor’s Degree | 50 (13.4) |
Master’s Degree | 35 (9.4) |
SES z-score | −0.1 ± 4.4 |
Charlson Comorbidity Indexb | 3.4 ± 1.8 |
Medication Regimen Complexity Index | 22.3 ± 12.1 |
Self-reported HF Severity at Baseline (NYHA) | |
Class I | 37 (9.9) |
Class II | 86 (23.1) |
Class III | 230 (61.8) |
Class IV | 19 (5.1) |
Depressive Symptoms (PHQ-9) (0–27) | 4.7 ± 4.9 |
Anxiety Symptoms (PROMIS-Anxiety) (5–35) | 13.0 ± 5.4 |
Social Support (MSPSS) (12–84) | 68.7 ± 14.5 |
Medical Term Recognition Test (METER) (0–40) | 35.3 ± 6.3 |
Cognitive Function T-scores (20–80) | |
Attention Composite | 44.4 ± 7.5 |
Stroop Word | 43.1 ± 9.4 |
Stroop Color | 45.2 ± 9.6 |
Trails A | 42.2 ± 10.4 |
Letter-Number Sequencing | 46.9 ± 10.5 |
Executive Function Composite | 45.8 ± 8.1 |
Stroop Color Word | 45.0 ± 10.2 |
Trails B | 41.4 ± 12.0 |
Frontal Assessment Battery | 50.9 ± 8.4 |
Memory Composite | 47.7 ± 7.9 |
Learning over Time | 49.3 ± 10.8 |
True Hits | 48.9 ± 9.1 |
Short Delay | 45.5 ± 10.9 |
Long Delay | 47.1 ± 9.5 |
Weight-related Variables | |
Average 21-Day Adherence (0–100%) | 76.5 ± 33.9 |
Adherent at least 80% of days | 221(71.8) |
Experienced weight-gain incidence (3lb/day) | 110(36.6) |
Baseline knowledge of when to call provider about weight gain | 131(35.3) |
Note. SES = socioeconomic status. HF = heart failure. NYHA = New York Heart Association. PHQ-9 = Patient Health Questionnaire-9. PROMIS-Anxiety = Patient Reported Outcomes Measurement Information System Anxiety Scale. MSPSS = Multidimensional Scale of Perceived Social Support. Means and standard deviations are presented for continuous variables. Sample size and percentages are presented for categorical variables.
Of the non-white participants, 96% identified as African American.
Most common comorbidities reported on the Charlson and corresponding % of participants: myocardial infarction (51.3%), diabetes (44.1%), and chronic obstructive pulmonary disease; COPD (27.4%).